source
- Vertex's $10 billion Crinetics buyout draws investor doubts over premium priceVertex was the lone bidder in a planned $10 billion acquisition of Crinetics Pharmaceuticals, a California company that focuses on endocrine medicines. Crinetics currently markets a therapy for a…
- Trump threatens 200% tariffs on imported generic drugs to force U.S. productionPresident Trump announced on Truth Social that generic drugs imported into the United States could face a 100% tariff starting Aug. 1, 2028, rising to 200% three years later. He framed the measure…